Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
Addmedica, array, arterial, ASH, Astra, atrial, attached, Behring, Cardurion, COBRA, Complexa, CSL, distinct, dysfunction, eighteen, Eli, ENTRESTO, erythroid, Farxiga, fifty, focal, Graphite, hundred, hypertension, Incl, Invokana, Jardiance, Johnson, letter, Lexicon, Lilly, lump, median, mice, mouse, nitrogen, nonrevocation, nuclear, PAH, Palatin, Pfizer, plasma, pulmonary, purport, ratio, reactivate, renal, salary, Silence, Society, subsidiary, TransThera, urea, urine, vehicle, Vifor, Zeneca, Zynquista
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view